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aLETTER TO THE EDITOR
The  need  for  antimicrobial  stewardship:  A  public
health  concern
To the  Editor,
History  has  demonstrated  that  the  introduction
of a  new  antibiotic  leads  to  its  widespread  use  and
the subsequent  development  of  inevitable  antibi-
otic  resistance.  Over  the  past  70  years  of  antibiotic
use in  clinical  practice,  bacteria  have  developed
resistance to  each  newly  introduced  antibiotic,  one
after another.  The  battle  against  antibiotic  resis-
tance has  continued  to  this  day,  but  alarmingly,
we are  not  able  to  develop  new  antibiotics  as  fast
as in  previous  years  [1],  and  bacteria  are  increas-
ingly becoming  resistant  to  multiple  antibiotics.
Therefore, efforts  should  be  directed  to  encour-
age more  investment  in  anti-infective  therapies  and
to delay  the  development  and  spread  of  resistance
by using  antibiotics  wisely  and  by  improving  infec-
tion control  measures.  The  implementation  of  such
a program  is  complicated  and  requires  a whole
systems approach.  To  be  successful,  an  antibiotic
stewardship program  should  be  multifaceted  and
should comprise  policies,  guidelines,  surveillance,
prevalence reports,  education,  and  audit  practices
to optimize  prescribing  methods.
It is  widely  accepted  that  there  is  a direct  cor-
relation between  the  use  of  antibiotics  and  the
development  of  antibiotic  resistance  [2,3]. There-
fore, antibiotic  stewardship  assumes  a high  priority
in every  healthcare  system.  Many  countries  con-
sider antibiotic  resistance  to  be  a  public  health
problem, and  discussions  are  held  to  inform
decision-making,  even  up  to  the  parliamentary
level. However,  despite  the  recognized  expertise
that is  required  to  prescribe  antibiotics  effectively,
this decision  process  is  often  left  to  junior  staff
who may  or  may  not  receive  instruction  from  their
seniors.  Patients  with  complicated  or  severe  infec-
tions are  often  managed  according  to  the  advice
from infectious  disease  physicians  or  specialist
microbiologists;  however,  the  majority  of  patients
are treated  for  their  infections  by  non-specialists.
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on-specialists opt  for  broad-spectrum  agents  and
reatment  durations  that  are  longer  than  necessary
ue to  the  gaps  in  their  knowledge  of  antibi-
tics use.  This  sub-optimal  prescribing  decision
rocess has  led  to  the  widespread  inappropriate
se of  antibiotics.  Several  studies  have  estimated
hat as  much  as  50%  of  hospital  antibiotic  pre-
cribing is  sub-optimal  [4—6].  At  our  institute,
iperacillin/tazobactam  is  widely  prescribed  and
esistance  in  Escherichia  coli  and  Klebsiella  pneu-
oniae  blood  isolates  has  more  than  doubled  over
 years  (Fig.  1).
Details  on  how  to  develop  an  antibiotic  steward-
hip program  are  beyond  the  scope  of  this  letter.
owever, the  appropriate  use  of  antibiotics  and
fforts  to  prevent  the  development  of  antibiotic
esistance should  be  a  top  priority  for  a  hos-
ital board.  Every  healthcare  institution  should
ave a local,  multi-disciplinary  antibiotic  man-
gement  group  that  is  responsible  for  developing
uidelines, policies,  and  restrictions  to  reduce  the
isk of  antibiotic  resistance  and  to  advice  on  the
ppropriate  antibiotic  use.  For  all  antibiotic  pre-
cribers,  there  should  be  ongoing  educational  and
raining activities  on  the  prudent  use  of  antibi-
tics, preferably  during  orientation  programs  and
very 3 years  thereafter.  Additionally,  audits  on  the
ifferent aspects  of  antibiotic  use  should  be  encour-
ged. Many  activity  materials,  toolkits,  pathways,
nd program  campaigns,  e.g.,  ‘Start  Smart,—Then
ocus,’ are  available  in  the  literature  [7]. Infec-
ions caused  by  resistant  organisms  have  a  high
olitical  proﬁle  and  are  a  top  priority  in  healthcare
gendas in  the  developed  world;  however,  antimi-
robial  stewardship  and  resistance  receive  much
ess attention  in  less  developed  countries  where
any  antibiotics  are  dispensed  over-the-counter.
It is  concerning  to  see  the  emergence  of  resis-
ance, especially  in  Gram-negative  bacteria,  at
 time  when  fewer  new  antimicrobial  agents
re being  approved.  A bacterial  population  that
s exposed  to  antibiotics  will  be  under  selec-
ive pressure  either  to  die  off  or  to  develop
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Figure  1  Piperacillin/tazobactam  resistant  Escherichia
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[oli  and  Klebsiella  pneumoniae  blood  isolates  from  2006
o  2012  at  Qatif  Central  Hospital.
esistance.  Mutants  with  reduced  susceptibility
o antibiotics  will  be  selected  against,  thereby
eading to  colonization  by  more  difﬁcult-to-treat
rganisms.  The  appropriate  use  of  antimicrobial
gents is  an  essential  part  of  patient  safety.  Public
ealth authorities  should  ensure  that  stewardship
easures are  in  place  to  promote  the  optimal
nd safe  use  of  antimicrobial  agents  to  mini-
ize the  acquisition  and  spread  of  resistance.  The
ombination  of  antimicrobial  stewardship  and  com-
rehensive  infection  control  measures  has  been
emonstrated  to  limit  the  emergence  and  transmis-
ion  of  antimicrobial-resistant  bacteria.
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